State-of-the-art in the management of chronic myelogenous leukemia in the era of the tyrosine kinase inhibitors: evolutionary trends in diagnosis, monitoring and treatment.

Source:http://linkedlifedata.com/resource/pubmed/id/20017605

Download in:

View as

General Info

PMID
20017605